Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
06/2013
06/12/2013CN102050689B Method for preparing beta-amino-alpha,beta unsaturated ester
06/12/2013CN101952261B Substituted cyclopentanes having prostaglanding activity
06/12/2013CN101723931B Method for synthesizing 4-thio-bicyclo [3.1.0]-2-hexene-6-formic ether
06/12/2013CN101704701B Method for reducing alkyne into cis-form olefin
06/12/2013CN101671291B Organic electroluminescent compounds and organic electroluminescent device using the same
06/12/2013CN101481325B Basic amino acid metalloproteinase inhibitor and use thereof
06/12/2013CN101258138B Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3-receptor ligands
06/11/2013US8461354 Organic thin film transistors comprising thienyl oligomers and their use as gaseous phase sensors
06/11/2013CA2683826C Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
06/06/2013US20130143765 Inhibitors of calcium-activated chloride channels
06/06/2013US20130142758 Novel hydroxamates as therapeutic agents
06/05/2013EP2598480A1 Cyclopropylamine derivatives useful as lsd1 inhibitors
06/05/2013EP2598141A2 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies
06/05/2013CN103140488A Compounds and compositions for mitigating tissue damage and lethality
06/05/2013CN103137647A Organic molecule memory, and organic molecule used in organic molecule memory
06/05/2013CN103130833A Soluble oxime ester and aromatic ketone photo polymerization initiator
06/05/2013CN103130745A Diaryl-piperazines compound and medical application thereof
06/05/2013CN103130705A Benzo five-membered unsaturated heterocyclic compound or pharmaceutically acceptable salt thereof, and preparation method, pharmaceutical composition and application thereof
06/05/2013CN103130680A High-optical-purity alkannin and Akannin naphthazarin nuclear parent hydroxyl methylation carbonyl oxime derivative and preparation method and application thereof
06/05/2013CN103127095A Synthesis and application of dihydrothiophenone derivative as pfDHODH inhibitor
06/05/2013CN101550047B Method of de-alkyl amine
06/05/2013CN101535289B Novel phenylacetic acid derivative
06/05/2013CN101133060B Enzyme inhibitors
06/04/2013US8455667 Duloxetine compositions in the form of a powder for suspension in a liquid
05/2013
05/30/2013WO2013075596A1 Pentabasic dihydrogen heterocyclic ketone derivative as dhodh inhibitor and use thereof
05/30/2013WO2013075399A1 Unsaturated 5-membered benzo-heterocyclic compound or pharmaceutical salts thereof, and preparation method, pharmaceutical composition and use thereof
05/30/2013WO2013075199A1 Acyl-hydrazone and oxadiazole compounds, pharmaceutical compositions containing the same and uses thereof
05/30/2013WO2013022385A3 Trialkoxysilanes, method for producing a cathode liner with a silane substrate, and an oxide capacitor with such a cathode liner
05/30/2013US20130137704 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
05/30/2013US20130136719 Compounds and methods for the treatment or prevention of flavivirus infections
05/29/2013EP2595975A2 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
05/29/2013EP2595952A1 Agonists of gpr40
05/29/2013EP2595747A1 Oxidative desulfurization using a titanium(iv) catalyst and organhoydroperoxides
05/28/2013US8450503 Photochromic and electrochromic compounds and methods of synthesizing and using same
05/28/2013US8450502 Pharmaceutical compositions for inhibiting angiogenesis
05/28/2013US8450501 Bidentate chiral ligands for use in catalytic asymmetric addition reactions
05/28/2013US8450363 Inhibitors of Jun N-terminal kinase
05/28/2013CA2561897C Thio-substituted biaryl-methanesulfinyl derivatives
05/28/2013CA2558647C Insecticidal n-substituted sulfoximines
05/28/2013CA2508990C Compounds and methods for the treatment or prevention of flavivirus infections
05/28/2013CA2508621C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
05/28/2013CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/23/2013WO2013071344A1 Urease inhibitor formulations
05/23/2013WO2012051318A8 Sulphonamide compounds and methods of making and using same
05/23/2013US20130131340 Ligands for estrogen related receptors and methods for synthesis of said ligands
05/22/2013EP2593528A1 Liquid-crystalline medium with stabilizer
05/22/2013CN103113247A Method for preparing amino-acid ester
05/22/2013CN103113176A Method for synthesizing N-alkenamide
05/22/2013CN103113174A Preparation method of phenolic compounds
05/22/2013CN101875651B Production method of 3-methyl sulfolane
05/21/2013US8445530 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
05/21/2013CA2396688C Glycosidase inhibitors and methods of synthesizing same
05/16/2013WO2013067578A1 Modulators of c3a receptors
05/16/2013US20130123514 Carbocatalysts for chemical transformations
05/16/2013US20130123265 Compounds that modulate intracellular calcium
05/16/2013US20130123242 Compounds and methods for the treatment or prevention of flavivirus infections
05/16/2013US20130121919 Histone acetyltransferase activators and uses thereof
05/15/2013CN103102329A Synthetic method of 2,3-dihydro-[1,4]-benzothiazine compound
05/15/2013CN103102283A Preparation method of chalcone oxime compound and application of the same as novel immunosuppressant
05/15/2013CN103102232A Styryl-based compound, composition containing styryl-based compound, and organic light emitting diode including styryl-based compound
05/15/2013CN103102230A O-aminophenyl chiral diallyl sulfide compound and its preparation method
05/15/2013CN102285961B Method for preparing chiral intermediate of duloxetine
05/15/2013CN102010399B Multiple thiophene group-containing photochromic compound
05/15/2013CN101215276B N,N'-substituted phenylpropylamino acid phenylpropylaminoalcohols esters derivatives and preparation method thereof
05/14/2013US8440854 Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at C-17
05/14/2013US8440844 Process for the preparation of β-amino alcohol
05/14/2013US8440843 2, 2-bipyridine ligand, sensitizing dye and dye sensitized solar cell
05/14/2013US8440713 [1]benzothieno[3,2-B][1]benzothiophene compound and method for producing the same, and organic electronic device using the same
05/09/2013US20130116318 Enzyme Inhibitors
05/09/2013US20130116227 Biaryl amide derivative or pharmaceutically acceptable salt thereof
05/08/2013EP2588447A1 Novel salts as anti-inflammatory, immunomodulatory and anti-proliferatory agents
05/08/2013EP2588446A1 Novel calcium salts of compound as anti-inflammatory, immunomodulatory and anti-proliferatory agents
05/08/2013CN103097339A Chalcone structure fluorescence dye for embryonic stem cell probe
05/08/2013CN103097338A Novel salts as anti-inflammatory, immunomodulatory and anti-proliferatory agents
05/08/2013CN103087723A Fluorine-containing dibenzothiophene sulfone single liquid crystal and preparation method and applications thereof
05/08/2013CN103087105A Chiral phosphine ligand and metal catalyst comprising same and application of chiral phosphine ligand and metal catalyst
05/08/2013CN103086934A Photoacid generator and photoresist comprising same
05/08/2013CN103086923A Hydrazine cathepsin K inhibitor and application thereof in treating osteoporosis
05/08/2013CN102093334B Method for synthesizing condensed ring thiophene compounds
05/08/2013CN101827817B Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides
05/08/2013CN101821236B Five-membered heterocyclic compound
05/08/2013CN101578265B Sulfonamide derivatives as chymase inhibitors
05/08/2013CN101218224B Compounds and methods for the treatment or prevention of flavivirus infections
05/07/2013US8436193 Method for manufacturing sulfolene compound and method for manufacturing sulfolane compound
05/07/2013CA2575073C Fungicidal composition containing acid amide derivative
05/07/2013CA2529154C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
05/02/2013WO2013063127A1 Cyclohexylamines
05/02/2013WO2013062065A1 Aminoalkyl-substituted n-thienyl benzamide derivative
05/02/2013WO2013060860A1 N-acyl-n'-phenylpiperazine derivatives as srbp modulators for use in the treatment of diabetes and obesity
05/02/2013WO2013059928A1 Hiv protease inhibitors
05/02/2013US20130109735 Salacinol and ponkoranol homologues, derivatives thereof, and methods of synthesizing same
05/02/2013CA2853688A1 Aminoalkyl-substituted n-thienylbenzamide derivative
05/02/2013CA2853279A1 Cyclohexylamines
05/01/2013EP2586434A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
05/01/2013EP2586433A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
05/01/2013EP2585448A1 Compounds and methods for the treatment or prevention of flavivirus infections
05/01/2013EP2585447A2 Compounds and methods for the treatment or prevention of flavivirus infections
05/01/2013CN103081155A Light-emitting element
05/01/2013CN103073534A Organic semiconductor material, and preparation method and application thereof
05/01/2013CN103073533A Method for extracting 2-methylthiophene and 3-methylthiophene with coking crude benzol
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 329